- Fee assured
- Verified account
Dr Miranda Payne is a Consultant in Medical Oncology, specialising in the treatment of skin cancers, with particular expertise in the systemic treatment of melanoma. Miranda took a first in Physiology from the University of Oxford before completing her clinical training in 1999. In 2006 Miranda was awarded a Cancer Research UK Clinical Fellowship, spending four years carrying our laboratory research in DNA repair at the Weatherall Institute of Molecular Medicine, leading to a DPhil in Medical Oncology from the University of Oxford. Specialist training was completed in Oxford , where she is now the Clinical Lead for Oncology at the Oxford University Hospitals NHS Foundation Trust.
Recruitment to international, academic, industry-sponsored and observational clinical trials is a routine aspect of Miranda’s clinical practice within the NHS, reflected in her publication record. She has a special interest in the consequences of immunotherapy and in the management of mucosal melanoma. Miranda is the Thames Valley and South Midlands Skin Cancer Research Lead, is an elected member of the National Cancer Research Institute Skin Group, is a co-author of the recently published UK guidelines for the management of both Ano-uro-genital Mucosal Melanoma and Head & Neck Mucosal Melanoma, works with Melanoma Focus (the UK national charity dedicated to research, treatment, education and information for patients, their families and their clinical teams) and has been an editor of the Oxford Handbook of Oncology for over 15 years.
Areas of interest
Systemic treatment of melanoma;
Systemic treatment of unresectable or metastatic cutaneous squamous cell carcinoma;
Systemic treatment of unresectable or metastatic basal cell carcinoma;
- Fellow of the Royal College of Physicians (London) Royal College of Physicians (London) 2019
- DPhil in Medical Onoclogy Oxford University 2011
Reference number 4648015